Search Results
Aug 12, 2026, 09:14 ET Borr Drilling Limited - Q2 2026 Presentation
https://edge.media-server.com/mmc/p/69yr7kfub) Conference CallPlease use this link to register for the conference call:
More news about: Borr Drilling Limited
Aug 12, 2026, 09:14 ET Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis
future, that would close the gap left by an aging donor population."The future of America's blood supply starts on college campuses," said Robert B. Ford, chairman and chief executive officer, Abbott. "When a young person gives blood for the first time and makes it a habit, that's potentially decades
More news about: Abbott
Aug 12, 2026, 09:01 ET Amplifica Completes $26 Million Series B Financing to Advance Injectable Pipeline for Hair Growth
clinical-stage biopharmaceutical company developing novel therapies for hair growth, today announced the closing of an oversubscribed $26 million Series B Preferred Stock financing. The financing was led by Tasso Partners, LLC, with participation from Eli Lilly and Company, principals of Scopia Capital Management,
More news about: Amplifica Holdings Group, Inc.
Aug 12, 2026, 09:00 ET Epoch Launches EpochX, Extending Its Events Platform to Enable Marketing Teams to Measure Event-Driven Pipeline
combine Questex and Emerald into a single B2B events platform, citing the value of in-person connection as AI reshapes how professionals meet and build relationships. The transaction signals renewed confidence that live events are an essential part of the modern B2B go-to-market strategy.Rather than
More news about: Epoch
Aug 12, 2026, 09:00 ET Pluxee apoia lançamento de manual do Pacto Global da ONU para fortalecer a comunicação ESG responsável
por tecnologia de ponta e por uma equipe de mais de 5.600 colaboradores ao redor do mundo, a Pluxee atua como parceira estratégica em um ecossistema B2B2C altamente conectado, que reúne mais de 500 mil empresas clientes, mais de 37 milhões de consumidores e mais de 1,7 milhão de estabelecimentos parceiros.
More news about: Pluxee
Aug 12, 2026, 09:00 ET DXC, DXC 워크플레이스 서비스로 업무의 새로운 시대를 열다
multimedia:https://www.prnewswire.com/kr/news-releases/u0064u0078u0063u002Cu002Du0064u0078u0063u002DuC6CCuD06CuD50CuB808uC774uC2A4u002DuC11CuBE44uC2A4uB85Cu002DuC5C5uBB34uC758u002DuC0C8uB85CuC6B4-302849460.htmlSOURCE
More news about: DXC Technology Company
Aug 12, 2026, 08:46 ET Borr Drilling Limited - Filing of Interim Financial Report on Form 6-K
https://mb.cision.com/Public/16983/4382557/b84c68cea02153e0.pdf Borr
More news about: Borr Drilling Limited
Aug 12, 2026, 08:39 ET TCL CSOT Advances Into Professional Esports and Powers the Future of AI Computing at ChinaJoy 2026
2026, TCL CSOT and LG unveiled the world's first Full HD 1080p native 1000Hz gaming monitor, the LG UltraGear™ model (25G590B). Designed to meet the TÜV Rheinland Native Gaming Performance Display Standard, the groundbreaking display marks the next step in TCL CSOT's gaming
More news about: TCL CSOT
Aug 12, 2026, 08:38 ET Certified B Corp™ Energy Efficiency Lender National Energy Improvement Fund, LLC (NEIF) Extends Successful 8.50% Preferred Investment Certificate Offering as Programs Expand
with Purpose" while earning an annual return of up to 8.50%, with quarterly payments of principal and interest. The investment support NEIF's B Corp™ mission of making essential energy upgrades (HVAC, insulation, roofing) more affordable and accessible to home and business owners nationwide.Since
More news about: National Energy Improvement Fund (NEIF)
Aug 12, 2026, 08:31 ET Dance Theatre of Harlem Galvanizes Arts Community with Inaugural Artistic Council
Robinson, recently Director of Choreography for Beyoncé's Renaissance World Tour, was hailed by The New York Times as "the most elevated hip-hop and R&B choreographer working today."Sanford Biggers is a multidisciplinary artist held in the permanent collections of MoMA and the Guggenheim,
More news about: Dance Theatre of Harlem
Aug 12, 2026, 08:30 ET Remepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson's Disease
venture capital fund founded in 2017 and backed by Eyal Ofer's Ofer Global, and focused primarily on early growth-stage investments, typically in Series B and C rounds. OGVP manages over $1.5 billion in assets under management (AUM). Its active portfolio includes companies such as Lendbuzz, Coralogix, Via,
More news about: Remepy
Aug 12, 2026, 08:15 ET Nexteer Reports Record First-Half 2026 Results
directors and employees assume (a) no obligation to correct or update the forward-looking statements or opinions contained in this press release; and (b) no liability in the event that any of the forward-looking statements or opinions do not materialize or turn out to be incorrect.ABOUT NEXTEER
More news about: Nexteer Automotive
Aug 12, 2026, 08:09 ET Iterion Therapeutics Strengthens Board with Additions of Manuel Aivado, MD, PhD and Bob Smith
goals.Tegavivint is a potent and selective first-in-class small molecule inhibitor of TBL1, a transcriptional co-activator that stabilizes nuclear b-catenin and plays a critical role in Wnt-driven oncogenic gene expression. By disrupting the nuclear TBL1:β-catenin complex, tegavivint promotes degradation
More news about: Iterion Therapeutics
Aug 12, 2026, 08:02 ET R-IT3, Inc. Files Four Provisional Patents Defining Precious Metals Recovery-to-Nanomaterials Platform
exchange for deploying our technology to slash their utility bills and capital expenditure on traditional power infrastructure." R-IT3, Inc. is a Certified B Corporation headquartered in Charlotte, North Carolina. Patent examination process is managed by NK Patent Law, with Ani Agrawal as lead attorney.About
More news about: R-it3,inc
Aug 12, 2026, 08:01 ET Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics
bacteremia with or without sepsis and/or infectious endocarditis, bone/joint infections, prosthetic joint infections and inhalational anthrax, caused by B. anthracis, a Bioterrorism Category A Threat-Level pathogen."About Acurx Pharmaceuticals, Inc. Acurx Pharmaceuticals is a late-stage
More news about: Acurx Pharmaceuticals, Inc.
Aug 12, 2026, 08:00 ET TACO BELL® AND TAJÍN® TEAM UP WITH PESO PLUMA FOR A NEW MENU LINEUP WORTH OBSESSING OVER
Peso Pluma, Tito Double P & Friends, which sold out completely. His global appeal has earned him collaborations with stars like Karol G, Cardi B, Ye, Yeat, Junior H, Quavo, Becky G, Eladio Carrión, Arcángel, and more, further propelling his impressive career. Peso Pluma is not only a musical powerhouse but
More news about: Taco Bell Corp.
Aug 12, 2026, 08:00 ET TACO BELL® Y TAJÍN® SE UNEN CON PESO PLUMA PARA LANZAR UN NUEVO MENÚ DIGNO DE OBSESIÓN
by Peso Pluma, Tito Double P & Friends, que agotó todas sus entradas. Su alcance global lo ha llevado a colaborar con artistas como Karol G, Cardi B, Ye, Yeat, Junior H, Quavo, Becky G, Eladio Carrión, Arcángel y muchos más, impulsando aún más su impresionante carrera. Peso Pluma no solo es una figura
More news about: Taco Bell Corp.
Aug 12, 2026, 07:49 ET Mach Travel Solutions Ltd Q1 FY27 Revenue Jumps 538% YoY to ₹144.33 Crore
organisation into a diversified, technology-enabled travel solutions platform spanning Corporate Travel, MICE, B2B, Leisure and Government & Institutional Projects, while also developing a B2C Online Travel Agency (OTA) platform.During the quarter, Mach executed large domestic and international
More news about: Mach Travel Solutions Limited
Aug 12, 2026, 07:39 ET Mach Travel Solutions Ltd Q1 FY27 Revenue Jumps 538% YoY to ₹144.33 Crore
organisation into a diversified, technology-enabled travel solutions platform spanning Corporate Travel, MICE, B2B, Leisure and Government & Institutional Projects, while also developing a B2C Online Travel Agency (OTA) platform.During the quarter, Mach executed large domestic and international
More news about: Mach Travel Solutions Limited
Aug 12, 2026, 07:07 ET Blacksmith Raises $45M Series B from Peak XV Partners as AI-Generated Code Drives Demand for Faster Code Validation
FRANCISCO, Aug. 12, 2026 /PRNewswire/ -- Blacksmith, a cloud for validating code, has raised a $45 million Series B led by Peak XV Partners, with existing investors Y Combinator and GV also participating. The round values the company at $550 million.
More news about: Blacksmith
Aug 12, 2026, 07:05 ET Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
strategy include, among others: (a) risks relating to the Company's operations and business, including the highly volatile nature of the price of ZEC; (b) the risk that material changes in the price of ZEC, such as decreases in price, will result in significant changes to the Company's financial statements,
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 07:05 ET Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
strategy include, among others: (a) risks relating to the Company's operations and business, including the highly volatile nature of the price of ZEC; (b) the risk that material changes in the price of ZEC, such as decreases in price, will result in significant changes to the Company's financial statements,
More news about: Cypherpunk Technologies Inc.
Aug 12, 2026, 07:00 ET AI Can Capture Conversations. But Who Turns Them Into Action?
Comu Official Website: https://bit.ly/4xvO64bOffer availability, promo code eligibility and inventory may vary by sales channel. Terms and conditions
More news about: Comu
Aug 12, 2026, 07:00 ET First Mining Announces 2026 Second Quarter Financial Results and Operating Highlights
required by law. Cautionary Note to United States Investors The Company is a "foreign private issuer" as defined in Rule 3b-4 under the United States Securities Exchange Act of 1934, as amended, and is eligible to rely upon the Canada-U.S. Multi-Jurisdictional Disclosure System,
More news about: First Mining Gold Corp.
Aug 12, 2026, 07:00 ET Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
Clinic.Key Findings from the PublicationDeFianCe (NCT05480306) was a two-part, randomized, open-label, multicenter Phase 2 study. Part B randomized 188 patients 1:1 to sirexatamab plus FOLFIRI or mFOLFOX6 and bevacizumab (Sirexatamab Arm) or to chemotherapy and bevacizumab alone (Control
More news about: Cypherpunk Technologies Inc.